...
首页> 外文期刊>Journal of Clinical Microbiology >Early detection of antibody to human immunodeficiency virus type 1 by using an antigen conjugate immunoassay correlates with the presence of immunoglobulin M antibody.
【24h】

Early detection of antibody to human immunodeficiency virus type 1 by using an antigen conjugate immunoassay correlates with the presence of immunoglobulin M antibody.

机译:通过使用抗原结合物免疫测定法早期检测针对1型人类免疫缺陷病毒的抗体与免疫球蛋白M抗体的存在有关。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Sequential plasma samples obtained from 16 individuals who seroconverted were tested for the presence of antibody to human immunodeficiency virus type 1 (HIV-1) by an antigen conjugate enzyme immunoassay (EIA) and a conventional antibody conjugate assay. In 11 of these individuals, the antigen conjugate assay detected antibody to HIV-1 2 to 11 days (mean, 5.5 days) earlier than the antibody conjugate assay. In 11 individuals, HIV-1 p24 antigen was detected a median of 6.5 days (range, 3 to 14 days) prior to positivity by the antigen conjugate EIA. Using class-specific probes, we determined the profiles of immunoglobulin M (IgM), IgG, and IgA antibodies for each individual and correlated these profiles with the EIA signals from both assays. In general, the appearance of IgM exhibited a peak at about 1 week postseroconversion, which was followed by gradually declining levels. Absorbance levels for IgG antibody, however, rose steadily and reached a plateau after 3 to 5 weeks. The levels of IgA were generally low and variable. In contrast to the progressive increase in EIA absorbance observed by the antibody conjugate assay, the antigen conjugate assay displayed a rapid early rise in absorbance which generally coincided with the transient expression of IgM antibody. The subsequent gradual increase coincided with rising levels of IgG. Because the configuration of the antigen conjugate EIA allows for an increased sensitivity for IgM compared with that for other classes of immunoglobulins, these results suggest that earlier detection of antibody to HIV-1 is due to the detection of IgM antibody during the early phase of seroconversion.
机译:通过抗原结合酶免疫测定(EIA)和常规抗体结合测定,测试了从16名血清转化的个体获得的顺序血浆样品中是否存在针对1型人类免疫缺陷病毒(HIV-1)的抗体。在这些个体中的11个人中,抗原结合物检测法比抗体结合物检测法早2至11天(平均5.5天)检测到HIV-1抗体。在11名个体中,在通过抗原结合物EIA阳性之前,检测到HIV-1 p24抗原的中位数为6.5天(范围3至14天)。使用类特异性探针,我们确定了每个个体的免疫球蛋白M(IgM),IgG和IgA抗体的概况,并将这些概况与两种测定的EIA信号相关联。通常,IgM的出现在血清转化后1周左右达到峰值,然后水平逐渐下降。但是,IgG抗体的吸光度水平稳定上升,并在3至5周后达到稳定水平。 IgA的水平通常较低且变化较大。与通过抗体结合物测定法观察到的EIA吸光度的逐渐增加相反,抗原结合物测定法显示出吸光度的快速早期升高,这通常与IgM抗体的瞬时表达相吻合。随后的逐渐增加与IgG水平的上升同时发生。由于与其他类别的免疫球蛋白相比,抗原缀合物EIA的构型可提高对IgM的敏感性,因此这些结果表明,较早检测到HIV-1的抗体是由于在血清转化的早期检测到了IgM抗体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号